CLYM

NASDAQ · Biotechnology

Climb Bio Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$14.29

+0.29 (+2.07%)

As of Aug 8, 1:58 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 20 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +82.7% upside

Low Target $17.52

Average Target $26.11

High Target $31.20

Current Price $14.29

Current
$14.29

Target
$26.11

$17.52 $26.11 avg $31.20

Scenario Analysis

Bear Case

$17.52

22.6%

Low target

Base Case

$26.11

+82.7%

Avg target

Bull Case

$31.20

+118.3%

High target

Risk/Reward

5.2x

Highly favorable

Price in Context

52-Week High

$14.42

-0.9% from high

52-Week Low

$1.54

+827.9% from low

Target vs 52W High

$26.11

+81.1% vs high

Next Earnings Report

Aug 18, 2026

until earnings

EPS Est: $-0.22

Earnings in 9 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%